» Articles » PMID: 21182496

Tuberous Sclerosis Complex: Tumors and Tumorigenesis

Overview
Journal Int J Dermatol
Specialty Dermatology
Date 2010 Dec 25
PMID 21182496
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Tuberous sclerosis complex (TSC) is an inherited disorder characterized by hamartomas in different body organs, mainly in the brain, skin, kidney, liver, lung, and heart. The clinical manifestations of TSC are the result of a mutation of one of two tumor suppressor genes, TSC1 and TSC2. Cutaneous findings in TSC should be regarded as cutaneous signs of a pivotal systemic disease. The authors elucidate the variety of neoplasms seen in TSC patients, along with their clinical significance, and suggest suitable evaluation and management strategies.

Citing Articles

Prenatal mTOR Inhibitors in Tuberous Sclerosis Complex: Current Insights and Future Directions.

Racioppi G, Proietti Checchi M, Sforza G, Voci A, Mazzone L, Valeriani M J Clin Med. 2024; 13(21).

PMID: 39518472 PMC: 11546097. DOI: 10.3390/jcm13216335.


Malignant tumors in tuberous sclerosis complex: a case report and review of the literature.

Liu C, Lele S, Goodenberger M, Reiser G, Christiansen A, Padussis J BMC Med Genomics. 2024; 17(1):144.

PMID: 38802873 PMC: 11129476. DOI: 10.1186/s12920-024-01913-8.


Successful Prenatal Treatment of Cardiac Rhabdomyoma in a Fetus with Tuberous Sclerosis.

Will J, Siedentopf N, Schmid O, Gruber T, Henrich W, Hertzberg C Pediatr Rep. 2023; 15(1):245-253.

PMID: 36976727 PMC: 10059978. DOI: 10.3390/pediatric15010020.


Management of Renal Angiomyolipomas in Tuberous Sclerosis Complex: A Case Report and Literature Review.

Hunter-Dickson M, Wu P, Athavale A, Wang A J Clin Med. 2022; 11(20).

PMID: 36294405 PMC: 9605548. DOI: 10.3390/jcm11206084.


Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results.

Ruiz-Falco Rojas M, Feucht M, Macaya A, Wilken B, Hahn A, Maamari R Front Pharmacol. 2022; 13:802334.

PMID: 35462939 PMC: 9023743. DOI: 10.3389/fphar.2022.802334.